.
The day’s gains came after a lackluster week for regional stocks, as a mix of low trading volumes, middling economic data and an uptrend in COVID-19 cases weighed on sentiment. Spain’s Grifols, one of the world’s top producers of treatments based on human plasma, gained 1.6 per cent.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: